Urolithin A Reduces Anxiety by Restoring Brain Mitochondrial Function
Gut metabolite urolithin A dramatically reduced anxiety in rodent models by fixing mitochondrial dysfunction in brain reward circuits.
Cognitive performance, neuroplasticity, dementia prevention, and brain aging research
478 articles
Gut metabolite urolithin A dramatically reduced anxiety in rodent models by fixing mitochondrial dysfunction in brain reward circuits.
Pomegranate metabolite urolithin A reduced brain damage and improved recovery in mouse stroke model by blocking inflammation and cell death.
New research reveals distinct protein signatures in skin samples that could help doctors accurately diagnose different neurodegenerative diseases.
New research shows essential tremor causes widespread brain damage beyond movement areas, potentially explaining cognitive symptoms.
Analysis of 177 cases with E200K mutation identifies new disease patterns that could improve diagnosis and understanding.
Study identifies specific genetic variants that increase glioma risk, potentially enabling targeted prevention and treatment strategies.
New research reveals tiny tau aggregates damage brain synapses before visible plaques form, offering early intervention targets.
Autopsy study of 162 patients shows cerebral amyloid angiopathy affects all brain regions equally, not just bleeding sites.
New research reveals how misfolded proteins cause fatal brain cell death in multiple system atrophy, offering potential treatment targets.
New spatial brain mapping identifies specific cortical layers most at risk and reveals how genetics influence dementia progression.
Scientists discover FAP protein reliably distinguishes deadly nerve cancers from benign tumors, enabling earlier detection.
New research reveals how early life adversity fundamentally alters how our brains age, affecting memory and decision-making abilities.